News

Ipsos Reveals Share and Voting Rights Data for 2024

Ipsos Reveals Share and Voting Rights Data for 2024

Understanding Ipsos' Latest Share and Voting Rights Disclosure

A recent announcement from Ipsos provided important insights into the company's share structure and voting rights, essential for investors and stakeholders. This disclosure is in line with the regulatory requirements that help maintain transparency in the financial markets.

Key Details from the Monthly Report

On September 30, 2024, Ipsos reported a total of 43,203,225 shares outstanding. These shares are the foundation of the company's governance structure and indicate the level of investor participation. The report further specifies voting rights attached to these shares, which are crucial in decision-making processes within the company.

Breakdown of Voting Rights

Voting rights are categorized into theoretical and exercisable rights, with the former including all shares, even those where voting rights have been suspended. As of the reporting date, the theoretical voting rights stood at 48,765,172. If we exclude the suspended voting rights, the exercisable voting rights total 48,642,976. This nuanced detail highlights the active engagement of shareholders in Ipsos' future directions.

Importance of Shareholder Engagement

Shareholders play a vital role in influencing how the company operates and makes decisions. Transparency in sharing this information is part of Ipsos' commitment to its investors and aligns with best practices in corporate governance. By keeping stakeholders informed, Ipsos fosters a stronger relationship built on trust and accountability.

Regulatory Compliance and Expectations

The monthly declaration aligns with Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulation of the AMF, underscoring the company's adherence to regulations. Such compliance not only fulfills legal obligations but also reassures investors about Ipsos' commitment to transparency.

Accessibility to Information

The information released is readily available in the "Regulated Information" section on Ipsos' official website. This ensures that all stakeholders can easily access the latest updates regarding shares and voting rights, helping them make informed decisions about their investments.

Attachment for Detailed Insights

For those seeking more detailed information, an attachment titled "Ipsos_Monthly declaration of voting rights_September 2024" is available, further elucidating the data presented in the report. Such resources are valuable for delving into the specifics and understanding the broader implications for shareholders.

Frequently Asked Questions

What is Ipsos' total number of shares as reported?

As of September 30, 2024, Ipsos reported a total of 43,203,225 shares outstanding.

How many voting rights are exercisable according to the report?

The exercisable voting rights totaled 48,642,976, indicating the shares that carry voting power for shareholders.

What are the theoretical voting rights mentioned?

The theoretical voting rights, which include all shares regardless of suspension of rights, are reported at 48,765,172.

Where can I find this disclosure information?

The disclosure information is available on the Ipsos website under the "Regulated Information" section.

What is the significance of this monthly disclosure?

This monthly disclosure is significant as it maintains transparency and informs shareholders about company governance, helping them in strategic decision-making.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 243

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 105

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 315

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 113

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 234

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 108

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading

Top 5 Most Recently Viewed Articles

WTW's Strategic Acquisitions: A Leap into the Future of Insurance

Updated Category News Views 178

WTW Expands Through Innovative Acquisitions Willis Towers Watson Public Ltd., known as WTW, is making headlines with its ambitious strategy to enhance its technology-enabled insurance and workplace benefits services. By announcing two consequential acquisitions, WTW aims to broaden its reach in the middle market while modernizing its client interactions significantly....

Continue Reading
Microsoft Faces Competition After Downgrade from D.A. Davidson

Updated Category News Views 120

Microsoft's Recent Downgrade by Analysts Analysts at D.A. Davidson have made headlines by downgrading Microsoft's (NASDAQ: MSFT) rating from Buy to Neutral. They have kept a price target of $475, reflecting ongoing evaluations of Microsoft's market strategies and performance. Factors Contributing to the Downgrade A key reason for this downgrade is the increasing...

Continue Reading
Portman Ridge Finance Faces Market Challenges with PTMN Stock

Updated Category News Views 133

Portman Ridge Finance Corporation Stock Overview In the current economic landscape, Portman Ridge Finance Corporation (NASDAQ: PTMN) has seen its stock touch a 52-week low, now priced at $16.19. This significant drop highlights a shift in investor sentiment, with key indicators such as the Relative Strength Index (RSI) signaling that the stock may be oversold. Notably,...

Continue Reading
Miami International Holdings Sees Growth in July Trading

Updated Category News Views 135

Miami International Holdings Reports Trading Results Miami International Holdings, Inc., a technology-driven leader in financial markets, has announced significant trading results for July 2025. The company operates several exchanges, including MIAX, MIAX Pearl, MIAX Emerald, MIAX Sapphire, and MIAX Futures. These results demonstrate a capacity for growth and stability in...

Continue Reading
Intel's Game-Changing Innovations at CES 2025 Unveiled

Updated Category News Views 220

Unveiling Innovations at CES 2025 At a highly anticipated event in Las Vegas, Intel took the stage at CES 2025 to reveal its latest technological advancements in mobile computing and edge solutions. With the launch of the new Intel Core Ultra (Series 2) processors, Intel is set to lead the charge in revolutionizing the way businesses, creators, and gaming enthusiasts...

Continue Reading